$Esperion Therapeutics (ESPR.US)$ All the Analysts raising their price target for a reason... we may see even 20% upside today or any other day and it would still be extremely undervalued. there's no reason not to see even $10 peak along 2026, based on improvement QoQ along the year. current price is considered as finders-keepers. this company has the legs and growth engines to reach even $10-12B Market Cap or around $40-50 valuation till 2030. really great investment in my eyes, short-mid-long term. you have it all in here.
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.Read more
Comments
to post a comment
2